Conference Correspondent

The findings of 2 separate studies presented at the recent European Society for Medical Oncology (ESMO) Congress suggest that oncology nurses need more education and training on how to manage adverse effects from cancer and its treatment.
Racial inequality in healthcare is a long-standing problem that has been studied for decades. The Accountability for Cancer Care through Undoing Racism and Equity (ACCURE) trial shows that it is possible to improve access to potentially curative care for African-American patients so that they are on a level playing field with white patients.
  • Challenges in ALK-Positive NSCLC Management
  • Lowering the High Cost of USP 800 Compliance
  • Navigating the New Requirements for USP 800 Drugs

Chicago, IL—The anaplastic lymphoma kinase (ALK) mutation is a target for tyrosine kinase therapies in several cancers, including non–small-cell lung cancer (NSCLC). Since 2011, several ALK inhibitors have been approved, and more are in the pipeline, but many questions remain for managing patients with ALK-positive NSCLC.

Chicago, IL—A clear set of standard operating procedures is at the heart of US Pharmacopeial Convention Chapter 800 (USP 800) compliance, according to Carol Yarrington, PharmD, BCOP, Oncology and Infusion Pharmacy Coordinator and Clinical Oncology Pharmacist, St. Joseph Mercy Health System, Ann Arbor, MI.

It is well-recognized that radiation-induced symptoms can be extremely severe for patients with head and neck cancer. Although “magic mouthwash” (ie, diphenhydramine plus lidocaine plus antacid [DLA]) is frequently used for the treatment of oral mucositis associated with radiotherapy to the head and neck, until now there has been no solid evidence for this approach.
Hypofractionated radiotherapy achieves comparable quality of life compared with conventional radiotherapy, and has the advantages of shorter treatment time, greater convenience to the patient, and less cost to the healthcare system compared with conventional radiotherapy.
Patients with cervical and endometrial cancers experience fewer gastrointestinal and genitourinary adverse events and have improved quality of life when they receive intensity-modulated radiation therapy (IMRT) compared with conventional radiation therapy.

Boston, MA—Hypofractionated radiotherapy achieves comparable quality of life compared with conventional radiotherapy, and has the advantages of shorter treatment time, greater convenience to the patient, and less cost to the healthcare system compared with conventional radiotherapy. The hypofractionated radiotherapy schedule is value-based, noted experts at the 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Boston, MA—It is well-recognized that radiation-induced symptoms can be extremely severe for patients with head and neck cancer. Although “magic mouthwash” (ie, diphenhydramine plus lidocaine plus antacid [DLA]) is frequently used for the treatment of oral mucositis associated with radiotherapy to the head and neck, until now there has been no solid evidence for this approach.

Page 3 of 29
Results 21 - 30 of 287